Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW YORK, NY, AND CAMBRIDGE, MA / ACCESS ...

Scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. One of the biggest hurdles in developing an HIV vaccine is ...

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...

Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

Scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. (Nanowerk News) One of the biggest hurdles in developing an HIV ...